EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and in vivo assessment reveal mechanisms targeting tumor metabolism, progression and drug resistance

Andres Machuca iD, Gabriel A Peñalver, Roberto Alvarez-Fernandez Garcia, Angelica Martinez-Lopez, Sonia Castillo-Lluva iD, Estefania Garcia-Calvo, Jose L Luque-Garcia iD

Journal of Materials Chemistry B · 2024

DOI: 10.1039/d4tb01631a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2024. Verfasst von Andres Machuca und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department Analytical Chemistry, Faculty of Chemical Sciences, Complutense University of Madrid, 28040, Madrid, Spain. jlluque@ucm.es. Hauptthemen laut MEDLINE: Photochemotherapy, Rhodium, Drug Resistance, Neoplasm, Proteomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Banco Santander, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhodium nanoparticles have been recently discovered as good photosensitizers with great potential in cancer photodynamic therapy by effectively inducing cytotoxicity in cancer cells under near-infrared laser.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyRhodiumDrug Resistance, NeoplasmProteomicsPhotosensitizing AgentsAntineoplastic AgentsHumansAnimalsMetal NanoparticlesApoptosisCell ProliferationChick EmbryoCell SurvivalNanoparticlesCell Line, TumorDrug Screening Assays, AntitumorNeoplasms

Substanzen

RhodiumPhotosensitizing AgentsAntineoplastic Agents

Autor:innen und Institutionen

  • Department Analytical Chemistry, Faculty of Chemical Sciences, Complutense University of Madrid, 28040, Madrid, Spain. jlluque@ucm.es.
  • Department Biochemistry and Molecular Biology, Faculty of Chemical Sciences, Complutense University of Madrid, 28040, Madrid, Spain.

ORCID-Profile: Andres Machuca, Sonia Castillo-Lluva, Jose L Luque-Garcia

Förderung

  • Banco Santander
  • Ministerio de Ciencia e Innovación

Zitieren

APA

Machuca, A., Peñalver, G. A., Garcia, R. A., Martinez-Lopez, A., Castillo-Lluva, S., Garcia-Calvo, E., & Luque-Garcia, J. L. (2024). Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and in vivo assessment reveal mechanisms targeting tumor metabolism, progression and drug resistance. Journal of Materials Chemistry B. https://doi.org/10.1039/d4tb01631a

Vancouver

Machuca A, Peñalver GA, Garcia RA, Martinez-Lopez A, Castillo-Lluva S, Garcia-Calvo E, et al. Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and in vivo assessment reveal mechanisms targeting tumor metabolism, progression and drug resistance. Journal of Materials Chemistry B. 2024. doi:10.1039/d4tb01631a

BibTeX
@article{Machuca2024,
  author = {Machuca, Andres and Peñalver, Gabriel A and Garcia, Roberto Alvarez-Fernandez and Martinez-Lopez, Angelica and Castillo-Lluva, Sonia and Garcia-Calvo, Estefania and Luque-Garcia, Jose L},
  title = {Advancing rhodium nanoparticle-based photodynamic cancer therapy: quantitative proteomics and in vivo assessment reveal mechanisms targeting tumor metabolism, progression and drug resistance},
  journal = {Journal of Materials Chemistry B},
  year = {2024},
  doi = {10.1039/d4tb01631a}
}
Kostenlos starten →